TrialThe American journal of cardiology2014

Mineralocorticoid receptor antagonist use in hospitalized patients with heart failure, reduced ejection fraction, and diabetes mellitus (from the EVEREST Trial).

Muthiah Vaduganathan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.